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1. Introduction
  Endotoxemia and sepsis occurs frequently in the patients 
leading to fulminant hepatic failure, which remains an 
extremely poor prognosis and high mortality due to the lack 
of effective preventives and therapies[1,2]. D-galactosamine 
(GalN)-induced acute liver injury in rats is a widely used 
as experimental animal model to investigate the underlying 
mechanisms of clinical fulminate hepatic failure and 
develop an effective therapeutic strategies to endotoxin 
challenge[3,4]. In this model, the liver injury critically 
depends on macrophage-derived pro-inflammatory 
cytokines, including TNF-毩, cyclooxygenase-2(COX-2), 
iNOS, interleukin-6 (IL-6) and NF-毷B. The macrophages 
of body tissues, especially Kupffer cells of liver, are known 
to largely contribute to the production of these cytotoxic and 
inflammatory mediators[5,6].
  TNF-毩 is the primary mediator of the systemic toxicity 
of endotoxin and secretion of cytokines such as IL-1, IL-6 
and IL-10 and activates in T-cells and other inflammatory 
cells[7]. The activation of the immune system has also been 
shown to play an important role in the development of 
liver diseases[8,9]. In this regard, recent reports of abnormal 
presence of a variety of cytokines, in particular, TNF-毩,
released from inflammatory cells are thought to be 
important for understanding in detail the mechanism 
of liver injury[10,11]. Nitric oxides (NOs) are well known 
pro-inflammatory mediators in the pathogenesis of 
inflammation[12]. NO produced by iNOS has been reported 
to have beneficial microbiocidal, anti-viral, anti-parasitic, 
and anti-tumoral effects[13]. However, sustained NO 
production can be deleterious to the host, and has been 
implicated in the pathogenesis of many inflammatory 
diseases[14]. Prostaglandin (PG), which is synthesized by 
COX, is another important mediator of inflammation[15]. 
Two distinct COX isoforms are well known. COX-1 
is constitutively expressed in nearly all tissues, and 
provides PGs to maintain physiological functions, such 
as, cytoprotection in the stomach and the regulation of 
renal blood flow. In contrast, COX-2 is induced by several 
proinflammatory stimuli, such as, growth factors, cytokines 
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and endotoxin. In particular, PGE2 is a major COX-2 product 
at inflammatory sites, where it contributes to local blood 
flow increase, edema formation, and pain sensitization[16,17].
  NF-毷B is one of most important transcription factors 
in terms of inflammatory responses, and controls 
the expressions of numerous genes, such as, iNOS, 
COX-2,  TNF-毩, IL-6, and IL-1毬[18,19].  NF-毷B
is predominantly a heterodimer composed of p65 and 
p50 subunits. In an unstimulated cell, NF-毷B is located 
in the cytoplasm due to binding with inhibitors of 毷B
(I毷Bs). However, pro-inflammatory stimuli cause I毷Bs to 
be rapidly phosphorylated and degraded via I毷B kinase 
complex, and liberated NF-毷B is then translocated to the 
nucleus, where it binds to its target sites and induces the 
transcriptions of pro-inflammatory mediators[20]. In addition, 
several studies have reported that the activation of NF-毷
B is triggered by mitogen-activated protein kinases, such 
as, extracellular signal-regulated kinase, p38 mitogen-
activated protein kinase, and c-Jun N-terminal kinase[21-23]. 
A major role of MAPKs is the regulation of cell growth and 
differentiation, as well as the control of cellular responses 
to cytokines and stresses. In particular, in stimulated 
macrophages, MAPK phosphorylation is known to be a 
prerequisite for the productions of NO and proinflammatory 
cytokines[21,24].
  Carvacrol, [2-methyl-5-(1-methylethyl)-phenol] is a 
predominant monoterpenic phenol which occurs in many 
essential oils[25]. Carvacrol was reported to produce a wide 
variety of pharmacological properties including anti-
inflammatory[26], antioxidant[27], antitumor[28,29]. In this 
study, we have evaluated the anti-inflammatory action of 
carvacrol in D-GalN hepatotoxic rats and no study has been 
carried out on these aspects so far.
2. Materials and methods
2.1. Chemicals
  
  D-galactosamine, carvacrol, primary and secondary 
antibodies for TNF-毩, IL-6, iNOS, COX-2 and NF-毷B 
were purchased from Sigma-Aldrich Co. (St. Louis, Missouri, 
USA). All other chemicals used were of analytical grade 
obtained from E. Merck or HIMEDIA, Mumbai, India. 
2.2. Animals
  Male albino Wistar rats (weighing 160-180 g) were procured 
from the Central Animal House, Department of Experimental 
Medicine, Rajah Muthiah Medical College and Hospital, 
Annamalai University and maintained in an air-conditioned 
room (25依1) 曟 with a 12 h light/12 h dark cycle. Feed and 
water were provided ad libitum to all the animals. The study 
was approved by the Institutional Animal Ethics Committee 
of Rajah Muthiah Medical College and Hospital (Reg 
no.160/1999/CPCSEA, Proposal number: 427), Annamalai 
University, Annamalainagar. 
2.3. Experimental induction of hepatotoxicity 
  Hepatotoxici ty  was  induced in  animals  by an 
intraperitoneal injection of D-galactosamine [400 mg/kg 
body weight(BW)] in a freshly prepared physiological saline 
as a single dose on the first day.
2.4. Experimental design 
  The animals were divided into five groups of six animals 
each as given below. Carvacrol and silymarin were 
administered orally once in a day in the morning for 6 d. 
  The compound was suspended in a 0.5% DMSO vehicle 
solution and fed by intubations.
Group 栺: Normal rats received 0.5% DMSO;
Group 栻: Normal + carvacrol (20 mg/kg BW);
Group 栿: D-GalN control (400 mg/kg BW) in saline;
Group 桇: D-GalN + carvacrol (20 mg/kg BW);
Group 桋: D-GalN + silymarin (25 mg/kg BW).
  On 8th day morning the animals were anesthetized by an 
intramuscular injection of ketamine (25 mg/kg BW) and 
sacrificed by cervical dislocation. Liver was removed, 
cleared off blood and immediately transferred to ice-cold 
containers containing saline and used for the determination 
of various inflammatory markers. 
2.5. Reverse transcription polymerase chain reaction (RT-
PCR)
  For total RNA, the liver tissue samples were minced and 
homogenized (100 mg/mL) in RNA isolation buffer. The 
homogenate was transferred to a 15 mL polypropylene tube 
and added in order: 0.1 mL of 2 M sodium acetate (pH 4.0), 
1 mL of saturated phenol (80%) and 0.2 mL CHCl3: isoamyl 
alcohol (49:1). Mixed thoroughly by inversion, following 
the addition of each reagent. After incubation on ice for
15 min, the samples were centrifuged at 10 000 rpm for 15 min
at 4 曟. To the aqueous phase equal volume of ice-
cold isopropanol was added and kept at -20 曟 for 1 h. 
The RNA was precipitated at 12 000 rpm for 15 min and 
washed with 80% ethanol. The pellet was dried briefly in 
vacuum and dissolved in minimal volume of sterile DEPC 
treated water. The amount of RNA was quantified by UV-
absorbance spectrophotometry. Total RNA (2 毺g) was 
reverse transcribed and 4 毺L cDNA obtained was used for 
polymerase chain reaction (PCR) amplification to estimate 
the expression of TNF-毩, IL-6, iNOS, COX-2 and  NF-毷B. 
GAPDH was used as an internal standard. Primer sequences 
and the resultant PCR products (Gene expressed) are listed 
in Table 1. After amplification, the PCR samples were 
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electrophoreses in 1.2% agarose gel stained with ethidium-
bromide. The bands were compared by a densitometer using 
‘Image J’ analysis software.
2.6. Primers used for SQRT-PCR studies in rats
Gene Primer sequence
TNF-毩  Forward, 5’-GTAGCCCACGTCGTAGCAAA-3’
              Reverse, 5’-CCCTTCTCCAGCTGGGAGAC-3’
IL-6  Forward: 5’- TCGAGCCCACCAGGAACGAAA -3’
              Reverse: 5’- TGGCTGGAAGTCTCTTGCG -3’
iNOS  Forward: 5’- GAGCCCTACGAGCCGTTGCC -3’
              Reverse: 5’- GCGAATGGTCCTGCGGCGTA -3’
COX-2  Forward: 5’- CCAGGGACCTGGCTTCCTTGTTCA -3’
              Reverse: 5’- TGGGGCAGTCTCCATTCGCA -3’
NF-毷B  Forward: 5’- CCGAGGTGGCAGGGGCAATG -3’
              Reverse: 5’- AGTGCAGGGCTGTGTCCCCA -3’
GAPDH  Forward, 5’- TCGAGTCTACTGGCGTCTT -3’
              Reverse, 5’- ATGAGCCCTTCCACGAT -3’.
2.7. Western blot analysis
  
   Cells were collected by centrifugation and washed once 
with phosphate buffered saline. The washed cell pellets 
were resuspended in lysis buffer (50 mM HEPES, pH 7.0, 
250 mM NaCl, 5 mM EDTA, 0.1% NP-40, 1 mM PMSF, 0.5 
mM DTT, 5 mM sodium fluoride (NaF), 0.5 mM sodium 
orthovanadate containing 5 毺g/mL each of leupeptin and 
aprotinin and incubated for 30 min at 4 曟. Cell debris 
was removed by centrifugation followed by quick freezing 
of the supernatants. The total protein concentration was 
determined by Bradford method. 60 毺g of protein from 
control and carvacrol treated proteins were electroblotted 
on to a nitrocellulose membrane after separation by 10% 
SDS-polyacrylamide gel electrophoresis. The blot was 
incubated for 1 h with blocking solution (5% skim milk) at 
room temperature after incubation for 4 h with a 1:1 000 
dilution of monoclonal anti- TNF-毩, IL-6, iNOS, COX-2, 
NF-毷B and 毬-actin antibodies (Santa Cruz Biotechnology 
Inc.). Blots were washed two times with tween 20/Tris 
buffered saline (TTBS) and incubated with a 1:2 000 dilution 
of alkaline phosphatase conjugated goat antimouse IgG 
secondary antibody for 2 h at room temperature. Blots were 
again washed 3 times with TTBS and then developed by 3, 
3’-diaminobenzidine tetrahydrochloride. Densitometry was 
done using ‘Image J’ analysis software.
2.8. Statistical analysis 
  Statistical evaluation was performed using one-way 
ANOVA followed by Duncan’s multiple range test using 
statistical package of social science (SPSS Inc., Chicago, IL, 
USA) 10.0 for Windows. Significance level was set at P<0.05.
3. Results
3.1. TNF-毩, IL-6, iNOS, COX-2 and NF-毷B mRNA 
expression 
  Figures 1, 2, 3, 4 and 5 show the effect of carvacrol on TNF-毩,
IL-6, iNOS, COX-2 and NF-毷B mRNA expression in 
D-galactosamine induced hepatotoxic rats, respectively. The 
mRNA expressions of TNF-毩, IL-6, iNOS, COX-2 and NF-
毷B were up-regulated significantly in D-galactosamine 
induced hepatotoxic rats while treatment with carvacrol 
significantly down-regulated the mRNA expressions.
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Figure 1. Agarose electrophorotogram of mRNA (a) and effect of 
carvacrol on TNF-毩 and IL-6 mRNA level in the liver of D-GalN 
hepatotoxic rats (b).
The data were expressed as ratio of TNF-毩 or IL-6/GAPDH. 
*P<0.05 compared with normal rats. Lanes: Normal rats-1; Normal 
+ carvacrol-2; D-GalN control-3; D-GalN + carvacrol-4; D-GalN 
+ silymarin-5. GAPDH-glyceraldehyde 3-phosphate dehydrogenase 
(internal standard).
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Figure 2. Band intensity scanned by densitometer (a) and effect of 
carvacrol on TNF-毩 and IL-6 mRNA level in the liver of D-GalN 
hepatotoxic rats (b).  
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Figure 3. Agarose electrophorotogram of mRNA (a) and effect of 
carvacrol on iNOS and COX-2 mRNA level in the liver of D-GalN 
hepatotoxic rats (b). 
The data were expressed as ratio of iNOS and COX-2/GAPDH. 
*P<0.05 compared with normal rats. Lanes: Normal rats-1; Normal 
+ carvacrol-2; D-GalN control-3; D-GalN + carvacrol-4; D-GalN 
+ silymarin-5. GAPDH-glyceraldehyde 3-phosphate dehydrogenase 
(internal standard).
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Figure 4.  Band intensity scanned by densitometer (a) and effect of 
carvacrol on iNOS and COX-2 mRNA level in the liver of D-GalN 
hepatotoxic rats (b).
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Figure 5. Effect of carvacrol on NF毷B mRNA level in the liver of 
D-GalN hepatotoxicity rats. 
a: Agarose electrophorotogram of mRNA. b: Band intensity scanned by 
densitometer. The data were expressed as ratio of NF毷B/GAPDH. *P<0.05 
compared with normal rats. Lanes: Normal rats-1; Normal + carvacrol-2; 
D-GalN control-3; D-GalN + carvacrol-4; D-GalN + silymarin-5. 
GAPDH-glyceraldehyde 3-phosphate dehydrogenase (internal standard). 
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Figure 6. Effect of carvacrol on TNF-毩, IL-6, iNOS, COX-2 and 
NF毷B protein expression in the liver of D-GalN hepatotoxic rats. 
a). TNF-毩, IL-6, iNOS, COX-2 and NF毷B protein expression by 
western blot. b). Band intensity scanned by densitometer. Histograms 
from densitometric analysis expressed as arbitrary units. *P<0.05 
compared with normal rats. Lanes: Normal rats-1; Normal + 
carvacrol-2; D-GalN control-3; D-GalN + carvacrol-4; D-GalN + 
silymarin-5. 
3.2. TNF-毩, IL-6, iNOS, COX-2 and NF-毷B protein 
expressions
  Figure 6 shows the effect of carvacrol on TNF-毩,
IL-6, iNOS, COX-2 and NF-毷B protein expressions 
in D-galactosamine induced hepatotoxic rats. The 
protein expressions were up-regulated significantly in 
D-galactosamine induced hepatotoxic rats and treatment 
with carvacrol significantly inhibited the protein expression 
of these genes.
4. Discussion
  
   D-GalN is thought to alter hepatic function by inhibiting 
hepatic mRNA synthesis through depleting uridine 
phosphates and uridine diphosphate sugars[30]. This results 
in an inability of the cells to produce important components 
of the cell membrane, leading to cell damage. The Kupffer 
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cells are thought to play a major role in response to 
inflammatory agents, mainly to those entering the circulation 
from the gut, which, in turn, promotes the expression of 
TNF-毩[31]. TNF-a is known to be a pleiotropic cytokine 
that contributes to the triggering of an inflammatory cascade 
involving the induction of cytokines including IL-1, 
IL-6, IFN-毭, nitric oxide and cell adhesion molecules, 
etc[32,33]. In respect of apoptosis, TNF-毩 combined with 
TNF-毩 receptor on the hepatocyte membrane activates 
caspase-3 and eventually induces apoptosis at an early 
stage through a series of signal transmission. It has been 
reported that TNF-毩-induced neutrophil transmigration 
at the later stages of liver injury has been shown to be a 
critical step in hepatocyte necrosis[34,35]. Therefore, TNF-毩
is in association with a wide range of inflammatory or 
auto-immune diseases including various liver lesions. 
IL-6 acts as a pro-inflammatory cytokine in the context of 
endotoxemia and acute liver failure. It is well known that 
IL-6 serum levels correlate with the severity of sepsis[36,37]. 
IL-6 can also enhance TNF-毩 induced apoptosis of 
hepatocytes sensitized by D-galactosamine[38]. In our 
study, D-GalN toxicity significantly upregulated the mRNA 
and protein expressions of hepatic TNF-毩 and IL-6 and 
treatment with carvacrol significantly reduced the mRNA 
and protein expression. The results implicated that carvacrol 
could attenuate inflammatory processes by suppressing the 
expression of TNF-毩 and IL-6 and thereby alleviating liver 
injury. 
  Recently, there has been much interest in the role of 
improper activation or up-regulation of iNOS or COX-2 in 
the pathogenesis of inflammatory disorders, including toxin-
induced liver damage[39,40]. The iNOS-catalyzed oxidative 
deamination of L-arginine to produce NO following exposure 
to pro-inflammatory cytokines (eg. TNF) or endotoxins (eg. 
lipopolysaccharide), could trigger disadvantageous cellular 
responses and may result in inflammation and sepsis[41]. 
COX-2 is another important inflammatory mediator 
through its rate-limiting synthesis of the precursors of 
prostaglandins and thromboxanes[42]. The consequence 
of high levels of iNOS and COX-2 causes the production 
of high concentrations of NO and eicosanoids through the 
initiation of the COX-prostanoid pathway, respectively[43,44], 
which cause cellular inflammation and necrosis. Treatment 
with carvacrol leads to a reduction in the expression level of 
both iNOS and COX-2. This may in part be the result of the 
regulatory activity and expression of NF-毷B. We propose 
that anti-inflammatory effect of carvacrol may in part be 
regulated by TNF-毩 and NF-毷B which could attenuate 
the downstream inflammatory process. In our recent 
study, we have shown that carvacrol treatment effectively 
diminished D-GalN-induced liver toxicity by reducing the 
oxidative stress[45]. In the present study showed that iNOS 
and COX-2 mediates acute D-GalN-induced liver injury 
and their inhibition by carvacrol exerts beneficial effects in 
the prevention of acute hepatic damage.
  In addition to inducing direct cellular damage, oxidative 
stress could activate transcription factors including NF-毷B
which regulate the expression of various inflammatory 
genes implicated in hepatotoxicity[46]. NF-毷B plays a 
key role in the process of inflammation. The expression 
of iNOS and COX-2 has been shown to be dependant on
NF-毷B activation[47]. Carvacrol significantly suppressed 
the expression of iNOS, COX-2, IL-6 and TNF-毩 genes. 
This was most likely due to suppression of NF-毷B. This is 
consistent with the reports that NF-毷B response elements 
are present on the promoter for the IL-6, iNOS, COX-2 and 
TNF-毩 genes[48-50]. In unstimulated cells, NF-毷B is found 
in cytoplasm and is bound to I毷B毩 and I毷B毬, which 
prevents it from entering the nuclei[51]. The release of NF-毷B
from I毷B results in the passage of NF-毷B into the nucleus, 
where it binds to specific sequence in the promoter region 
of target genes. In the present study, carvacrol significantly 
suppressed the expression of NF-毷B probably through the 
inhibition of degradation of I毷B, which, in turn, suppressed 
the expression of TNF-毩, IL-6, COX-2 and iNOS genes. 
  Thus, the administration of carvacrol suppressed hepatic 
injury in rats by inhibiting the TNF-毩, IL-6, COX-2, 
iNOS and NF-毷B mRNA and protein expressions in liver. 
Our results thus provide a mechanistic basis for the anti-
inflammatory activity of carvacrol.
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